---
figid: PMC7737321__pt0c00144_0001
figtitle: 'Empagliflozin and Doxorubicin Synergistically Inhibit the Survival of Triple-Negative
  Breast Cancer Cells via Interfering with the mTOR Pathway and Inhibition of Calmodulin:
  In Vitro and Molecular Docking Studies'
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC7737321
filename: pt0c00144_0001.jpg
figlink: /pmc/articles/PMC7737321/figure/fig1/
number: F1
caption: Graphical representation showing that adding EMP enhances the anticancer
  effects of DOX at a reduced concentration, suggesting that EMP could minimize adverse
  effects of DOX while preserving its therapeutic value.
papertitle: 'Empagliflozin and Doxorubicin Synergistically Inhibit the Survival of
  Triple-Negative Breast Cancer Cells via Interfering with the mTOR Pathway and Inhibition
  of Calmodulin: In Vitro and Molecular Docking Studies.'
reftext: Shenouda G. Eliaa, et al. ACS Pharmacol Transl Sci. 2020 Dec 11;3(6):1330-1338.
year: '2020'
doi: 10.1021/acsptsci.0c00144
journal_title: ACS Pharmacology & Translational Science
journal_nlm_ta: ACS Pharmacol Transl Sci
publisher_name: |-
  American
  Chemical Society
keywords: |-
  TNBC | EMP | calmodulin
  antagonist | docking | apoptosis
automl_pathway: 0.8811682
figid_alias: PMC7737321__F1
figtype: Figure
redirect_from: /figures/PMC7737321__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7737321__pt0c00144_0001.html
  '@type': Dataset
  description: Graphical representation showing that adding EMP enhances the anticancer
    effects of DOX at a reduced concentration, suggesting that EMP could minimize
    adverse effects of DOX while preserving its therapeutic value.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ca
  - per
  - Mtor
  - Tor
  - Debcl
  - bsk
  - dap
  - PER1
  - MTOR
  - BCL2
  - MAPK8
  - MAPK9
  - MAPK10
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
---
